Oncology Institute, Inc. Ratios

Ratios Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
Gross Margin 48.94%51.03%46.63%44.17%52.50%
EBT Margin -7.90%-5.71%-0.04%-25.63%-16.44%
EBIT Margin -4.37%-22.59%-32.46%-23.75%-15.28%
EBITDA Margin -4.00%-22.18%-31.85%-22.87%-14.47%
Operating Margin -4.37%-22.59%-32.46%-23.75%-15.28%
Net Margin -3.41%-5.24%-6.73%-20.93%-13.47%
FCF Margin -0.37%-17.50%-26.65%-12.61%-7.71%
Efficiency
Inventory Average 5.40M7.85M11.47M11.86M
Assets Average 134.56M232.55M235.45M190.98M
Equity Average 66.13M113.67M90.10M30.31M
Invested Capital 33.47M104.34M203.80M143.85M96.72M
Asset Utilization Ratio 1.511.091.382.06
Leverage & Solvency
Interest Coverage Ratio -23.62-143.31-11.36-8.02
Debt to Equity 0.420.000.651.5225.95
Debt Ratio 0.180.000.310.410.54
Equity Ratio 0.430.510.470.270.02
Times Interest Earned -23.62-143.31-11.36-8.02
Valuation
Enterprise Value 304.50M599.00M45.56M67.59M41.99M
Market Capitalization 310.50M714.18M119.36M150.45M91.66M
Return Ratios
Return on Sales -0.08%-0.05%0.00%-0.26%-0.16%
Return on Capital Employed -0.44%-0.40%-0.38%-0.43%
Return on Invested Capital -0.63%-0.44%
Return on Assets -0.08%0.00%-0.35%-0.34%
Return on Equity -0.17%0.00%-0.92%-2.13%